Kodiak Sciences (KOD) Interest Expenses (2017 - 2023)
Kodiak Sciences' (KOD) quarterly Interest Expenses came in at $464.4 million in Q1 2026, up 24381.44% YoY from N/an in Q1 2025, and up 41.47% on a QoQ basis from $328.3 million in Q4 2025.
Analysis
Kodiak Sciences (KOD) Interest Expenses (2017 - 2023) Analysis & Trends
Kodiak Sciences (KOD) has 10 years of Interest Expenses data on file, last reported at $464.4 million in Q1 2026.
- Quarterly Interest Expenses rose 24381.44% year-over-year to $464.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $464.4 million (up 24381.44% YoY) and the FY2025 annual result came in at $328.3 million, up 32.79% from the prior year.
- Interest Expenses improved to $464.4 million in Q1 2026, from $328.3 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $464.4 million in Q1 2026 to a low of $4000.0 in Q4 2022.
- A 5-year average of $59.7 million and a median of $5.0 million in 2023 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses tumbled 98.91% — and 2023, when it surged 378500.0%.
- Tracing KOD's Interest Expenses over 5 years: stood at $4000.0 in 2022, then surged by 378500.0% to $15.1 million in 2023, then sank by 94.06% to $900000.0 in 2024, then soared by 36375.78% to $328.3 million in 2025, then soared by 41.47% to $464.4 million in 2026.
- The last three Interest Expenses figures came in at $464.4 million (Q1 2026), $328.3 million (Q4 2025), and $166.6 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Kodiak Sciences | 2.21 Bn | 2.21 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Sep 30, 2020 | 6,000.00 |
| Jun 30, 2020 | 6,000.00 |
| Mar 31, 2020 | 7,000.00 |
| Sep 30, 2019 | 2,000.00 |
| Jun 30, 2019 | 2,000.00 |
| Mar 31, 2019 | 4,000.00 |
| Dec 31, 2018 | 190,000.00 |
| Sep 30, 2018 | 1.98 Mn |